Heather S. Han, MD

Where You Are:

Heather S. Han, MD

Medical Oncology

For Consultation Requests or Referrals: (888) 860-2778

 
 

BOARD CERTIFICATION:
          •  Medical Oncology
          •  Hematology

FELLOWSHIP:
          •  University of Miami/Jackson Memorial Hospital - Hematology/Oncology

RESIDENCY:
          •  Cleveland Clinic Foundation - Internal Medicine

MEDICAL SCHOOL:
          •  Seoul University College of Medicine - MD

  • Malo TL, Lipkus I, Wilson T, Han HS, Acs G, Vadaparampil ST. Treatment Choices Based on OncotypeDx in the Breast Oncology Care Setting. J Cancer Epidemiol. 2012;2012:941495. Pubmedid: 22927848. Pmcid: PMC3425834.

  • Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Gl?ck S. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Eur J Cancer. 2011 Nov;47(17):2537-2545. Pubmedid: 21741825.

  • Lee MC, Gray J, Han HS, Plosker S. Fertility and reproductive considerations in premenopausal patients with breast cancer. Cancer Control. 2010 Jul;17(3):162-172. Pubmedid: 20664513.

  • Biagioli MC, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, Han HS, Markoe A. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007 Nov;69(4):1067-1073. Pubmedid: 17967302.

  • Han H, Rybicki L, Thiel K, Kalaycio M, Sobecks R, Advani A, Brown S, Sekeres M. White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia. Leuk Lymphoma. 2007 Aug;48(8):1561-1568. Pubmedid: 17701588.

  • Hirasawa K, Jun HS, Han HS, Zhang ML, Hollenberg MD, Yoon JW. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages. J Virol. 1999 Oct;73(10):8541-8548. Pubmedid: 10482607. Pmcid: PMC112874.

Dr. Heather Han is a medical oncologist specializing in breast cancer in The Center for Women’s Oncology at Moffitt Cancer Center.  She is dedicated to helping find a cure for the millions of women whose lives have been affected by a diagnosis of breast cancer.

Dr. Han finds that Moffitt Cancer Center offers a unique health care environment in that outstanding physicians in every discipline work together for a common cause in the battle against cancer.  She believes that the future of cancer is to provide personalized treatment for every patient.  Moffitt’s Total Cancer Care initiative is making great strides toward this goal.

Dr. Han is currently researching outcomes among breast cancer patients of different nationalities, including Asian, African American, Hispanic and Caucasian, to determine whether race may have an impact on disparities in chemotherapy toxicity.  She is also a principal investigator for phase one and phase two clinical trials evaluating novel targeted breast cancer therapies designed to improve prognosis, reduce side-effects and improve quality of life. 

Dr. Han enjoys the opportunity to participate in Moffitt’s medical oncology fellowship program, serving as an instructor and mentor for the outstanding medical oncologists of the future.

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions